Contrary to the findings of previous studies, 800 mg/d of DHA delivered via fish oil capsules does not lower levels of postpartum depression in mothers or improve cognitive or language development in their offspring during early childhood, according to one trial.
Contrary to the findings of previous studies, 800 mg/d of docosahexaenoic acid (DHA) delivered via fish oil capsules does not lower levels of postpartum depression in mothers or improve cognitive or language development in their offspring during early childhood, according to a double-blind, randomized trial from Australia.
The study involved more than 2,000 women with singleton pregnancies of less than 21 weeks' gestation.
Researchers found that the percentage of women with high levels of depressive symptoms during the first 6 months postpartum did not differ between the group of women who took the DHA-filled capsules versus the group who took vegetable oil capsules without DHA (9.67% vs 11.19%; adjusted relative risk [RR], 0.85; 95% CI, 0.70-1.02; P=.09).
Makrides M, Gibson RA, McPhee AJ, et al; DOMInO Investigative Team. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA. 2010;304(15):1675-1683.
EHR-based models show promise in predicting postpartum depression
December 24th 2024Recent research published highlights the potential of electronic health record data to improve postpartum depression diagnosis, offering a step toward better mental health outcomes for birthing parents.
Read More
Midlife sexual health boosts for nonheterosexual women reported
December 23rd 2024A recent study highlights improved sexual function and reduced distress among nonheterosexual women during menopause compared to their heterosexual counterparts, shedding light on how sexual identity impacts well-being.
Read More